Form 8-K - Current report:
SEC Accession No. 0001193125-25-028247
Filing Date
2025-02-18
Accepted
2025-02-18 09:03:55
Documents
14
Period of Report
2025-02-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d934523d8k.htm   iXBRL 8-K 24799
2 EX-99.1 d934523dex991.htm EX-99.1 12105
  Complete submission text file 0001193125-25-028247.txt   167151

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sepn-20250218.xsd EX-101.SCH 2515
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sepn-20250218_lab.xml EX-101.LAB 18700
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sepn-20250218_pre.xml EX-101.PRE 11687
16 EXTRACTED XBRL INSTANCE DOCUMENT d934523d8k_htm.xml XML 3870
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42382 | Film No.: 25632959
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)